GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lyka Labs LYKALABS.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

80.60

+2.52%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹1.28bn

FY2017FY2026

Net income

−₹100.3m

FY2017FY2026

Free cash flow

−₹75.2m

FY2017FY2026

Shareholders' equity

₹923.9m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹1.28bn₹1.41bn₹1.05bn₹916.9m₹1.84bn₹671.1m₹554.1m₹642.4m₹563.6m₹993.8m
Research and development—₹9.8m₹13.9m₹14.3m—————₹4.8m
Operating income−₹121.2m₹505.0m₹15.0m₹16.1m₹830.9m₹113.6m−₹202.2m−₹89.6m−₹130.4m₹125.2m
Net income−₹100.3m₹80.1m−₹24.9m−₹132.1m₹390.0m−₹115.5m−₹605.4m−₹55.5m−₹172.7m−₹55.4m
Diluted earnings per share-2.772.24-0.69-3.9313.63-4.01-21.38-1.95-5.54-2.47

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹1.75bn₹1.76bn₹1.57bn₹1.52bn₹1.86bn₹1.90bn₹2.00bn₹2.17bn₹2.35bn₹2.48bn
Cash and short-term investments₹13.8m₹13.6m₹62.9m₹119.4m₹21.6m₹76.3m₹107.9m₹27.2m₹16.2m₹51.2m
Total liabilities₹837.1m₹726.2m₹884.6m₹1.06bn₹1.72bn₹2.15bn₹2.15bn₹1.72bn₹1.77bn₹2.06bn
Debt₹488.7m₹391.8m₹586.5m₹751.0m₹1.30bn₹1.63bn₹1.42bn₹964.2m₹1.13bn₹1.25bn
Shareholders' equity₹923.9m₹1.04bn₹681.5m₹454.4m₹133.4m−₹258.0m−₹143.4m₹448.1m₹530.0m₹392.0m
Shares outstanding36m36m36m34m29m29m28m28m31m22m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹36.1m₹19.0m₹17.7m₹89.5m₹792.5m₹88.1m₹53.2m₹266.7m₹108.8m₹313.8m
Capital spending−₹111.3m−₹156.5m−₹92.3m−₹81.9m−₹75.1m−₹12.7m−₹11.0m−₹48.2m−₹36.2m−₹133.9m
Free cash flow−₹75.2m−₹137.6m−₹74.6m₹7.7m₹717.3m₹75.4m₹42.3m₹218.5m₹72.6m₹179.9m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹423.1m₹280.3m₹307.3m₹366.6m₹330.3m₹342.5m₹338.0m₹411.6m
Operating income₹25.4m−₹85.0m−₹5.1m−₹46.9m₹15.7m₹34.9m₹41.9m₹31.9m
Net income₹20.7m−₹76.1m−₹2,000−₹33.6m₹9.3m₹17.7m₹27.1m₹21.0m
Diluted earnings per share0.57-2.10-0.00-0.940.260.500.750.58
Cash from operations———₹136.0m—₹18.0m—₹7.0m
Capital spending———−₹85.0m—−₹156.0m—−₹81.0m
Free cash flow———₹51.0m—−₹138.0m—−₹74.0m
Total assets—₹1.75bn—₹1.68bn—₹1.76bn—₹1.68bn
Cash and short-term investments₹18.9m₹13.8m₹11.9m₹11.9m₹18.4m₹13.6m₹11.3m₹11.3m
Debt—₹488.7m—₹316.6m—₹391.8m—₹351.6m
Shareholders' equity₹908.3m₹923.9m₹1.01bn₹1.01bn₹1.04bn₹1.04bn₹986.9m₹989.1m

Financial ratios

Data as of 27 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2017FY2014
Operating margin-9.4%9.5%3.8%-1.4%45.7%17.6%——
Net margin-7.8%5.7%-2.4%-14.4%21.2%-17.2%——
Return on equity-10.9%7.7%-3.7%-29.1%292.4%44.8%——
Return on assets-5.7%4.5%-1.6%-8.7%21.0%-6.1%——
Free cash flow yield5.2%6.2%3.9%6.5%38.4%4.4%——
Revenue growth-8.7%33.9%14.7%-50.1%173.6%21.1%——
Earnings growth-225.2%-421.8%-81.2%-133.9%-437.5%-80.9%——
Current ratio1.17x1.45x1.35x1.36x0.53x0.58x——
Debt to equity0.53x0.37x0.84x1.61x9.78x-6.32x——
Equity ratio52.9%58.8%43.5%30.0%7.2%-13.6%——
Interest coverage-3.83x5.90x0.81x-0.11x4.16x0.45x——
R&D as a share of sales0.2%0.7%1.3%1.6%——0.5%2.0%
Buybacks as a share of market value-1.3%1.2%-7.5%-17.4%0.8%-1.9%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue11.9%13.9%0.1%
Net income-8.8%-2.8%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin14.3%8.9%19.0%10.2%
Net margin-0.8%-3.8%1.4%-6.7%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-27.233.8-228.9-31.59.5-55.5-1.4-10.0-5.5-26.1
Price to sales2.11.95.44.52.09.61.60.91.71.5

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 12 Aug 1996.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.